Literature DB >> 11878782

Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer.

D K Strickland1, J J Jenkins, M M Hudson.   

Abstract

The results of preliminary reports of childhood cancer survivors with hepatitis C infection (HCV) show that in none of these patients did the disease progress to liver failure or hepatocellular carcinoma (HCC). The authors describe two patients who were diagnosed with HCC more than 20 years after the treatment of childhood acute lymphocytic leukemia. Serologic testing, done at the time HCC was diagnosed, found HCV-directed antibodies, suggesting that chronic HCV infection contributed to the development of the subsequent neoplasm. Identification of infected patients will permit intervention to reduce the risk of progressive liver disease and will also assist in defining the risk of and variables contributing to progressive liver disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11878782     DOI: 10.1097/00043426-200111000-00012

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  7 in total

Review 1.  Cirrhosis in children and adolescents: An overview.

Authors:  Raquel Borges Pinto; Ana Claudia Reis Schneider; Themis Reverbel da Silveira
Journal:  World J Hepatol       Date:  2015-03-27

2.  Hepatitis C virus infection in mothers and children.

Authors:  Emma Greenaway; Mia J Biondi; Jordan J Feld; Simon C Ling
Journal:  Can Liver J       Date:  2019-12-10

Review 3.  Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group.

Authors:  Sharon Castellino; Andrew Muir; Ami Shah; Sheila Shope; Kevin McMullen; Kathy Ruble; Ashley Barber; Andrew Davidoff; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2010-05       Impact factor: 3.167

4.  Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study.

Authors:  Meagan Lansdale; Sharon Castellino; Neyssa Marina; Pamela Goodman; Melissa M Hudson; Ann C Mertens; Stephanie M Smith; Wendy Leisenring; Leslie L Robison; Kevin C Oeffinger
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

Review 5.  Burden of pediatric hepatitis C.

Authors:  Mortada Hassan El-Shabrawi; Naglaa Mohamed Kamal
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

6.  Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C.

Authors:  Kathleen B Schwarz; Philip Rosenthal; Karen F Murray; Jonathan R Honegger; Winita Hardikar; Rosie Hague; Naveen Mittal; Benedetta Massetto; Diana M Brainard; Chia-Hsiang Hsueh; Jiang Shao; Bandita Parhy; Michael R Narkewicz; Girish S Rao; Suzanne Whitworth; Sanjay Bansal; William F Balistreri
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

7.  Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection.

Authors:  Philip Rosenthal; Kathleen B Schwarz; Regino P Gonzalez-Peralta; Chuan-Hao Lin; Deidre A Kelly; Scott Nightingale; William F Balistreri; Sanjay Bansal; Maureen M Jonas; Benedetta Massetto; Diana M Brainard; Chia-Hsiang Hsueh; Jiang Shao; Bandita Parhy; Suzanne Davison; Cornelia Feiterna-Sperling; Lynette A Gillis; Giuseppe Indolfi; Etienne M Sokal; Karen F Murray; Stefan Wirth
Journal:  Hepatology       Date:  2019-08-13       Impact factor: 17.425

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.